GrowthCurve Capital takes majority stake in TailorMed
TailorMed, which runs a network-powered medication success platform, receives a majority investment from GrowthCurve Capital.
GrowthCurve Capital
1 deals covered
1 platform
Most recent deal Monday, November 2, 2026.